Evidence map›Paper›PMID 42676651›Full record

ArticleFrontiers in immunology2026

Pollutant particle priming amplifies airway compartment specific neutrophil and macrophage inflammatory programs following house dust mite acute exposure.

Kirsty Meldrum, Martin Oliver Leonard

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kirsty MeldrumToxicology Department, UK Health Security Agency, Harwell Campus, Chilton, United Kingdom.
Martin Oliver LeonardToxicology Department, UK Health Security Agency, Harwell Campus, Chilton, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real world inhalation exposures occur as temporally staggered mixtures of environmental pollutants and indoor allergens, yet the mechanistic consequences of sequential exposure remain poorly defined. Here, we investigated whether diesel exhaust particle (DEP) exposure primes the lung to alter subsequent responses to house dust mite (HDM) allergen independently of direct co-exposure or preexisting sensitisation. Using a murine model with defined temporal separation between exposures, we combined compartment resolved bulk transcriptomics and targeted single cell profiling to map inflammatory and cellular responses across lung tissue and airway lumen. DEP priming significantly amplified leukocyte recruitment following HDM challenge, with a dominant increase in neutrophils and no corresponding eosinophilic response. Transcriptomic analyses revealed that DEP alone preferentially induced NF-κB associated inflammatory programs, while HDM triggered both NF-κB and interferon (IFN) associated transcriptional responses. Importantly, DEP priming qualitatively reprogrammed the allergen response, enhancing both IFN stimulated gene (ISG) expression and pro-inflammatory cytokine networks. These effects were most pronounced in the airway luminal compartment, indicating a prominent inflammatory niche shaped by recruited immune cells. Single cell analyses identified expansion and activation of multiple neutrophil subpopulations, alongside recruitment of macrophage subsets, NK cells, and CD8

Indexed as

Air PollutantsLungMacrophagesNeutrophilsPyroglyphidaeVehicle EmissionsAllergensAnimalsAntigens, DermatophagoidesCytokinesFemaleInhalation ExposureMiceAir PollutantsAllergensAntigens, DermatophagoidesCytokinesVehicle Emissionsallergeninflammationluminal airwaylungparticlepollutantprimingsingle cell sequencing (scRNA-seq)

Identifiers

PMID42676651
PMCPMC13527561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.